These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3787614)

  • 21. Autoreactive T cell clones of MHC class II specificities are produced during responses against foreign antigens in man.
    Tilkin AF; Michon J; Juy D; Kayibanda M; Henin Y; Sterkers G; Betuel H; Lévy JP
    J Immunol; 1987 Feb; 138(3):674-9. PubMed ID: 3492528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
    van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
    Fischer A; Sterkers G; Charron D; Durandy A
    Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope analysis with monoclonal antibodies directed against class II molecules subdivides HLA-DR2, DR3 and DR4: correlations with cellularly defined Dw specificities.
    Johnson JP; Nordwig H; Wank R
    Tissue Antigens; 1987 Jan; 29(1):26-33. PubMed ID: 2438806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response to Toxoplasma gondii--analysis of suppressor T cells in a patient with symptomatic acute toxoplasmosis.
    Yano A; Norose K; Yamashita K; Aosai F; Sugane K; Segawa K; Hayashi S
    J Parasitol; 1987 Oct; 73(5):954-61. PubMed ID: 2958613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
    Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
    J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of HLA specificity of human monoclonal antibodies by cytofluorimetry and cell ELISA.
    Pistillo MP; Tazzari PL; Mazzoleni O; Urlacher A; Falco M; Vitale M; Karr RW; Ferrara GB
    Eur J Immunogenet; 1991; 18(5-6):345-53. PubMed ID: 1772879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of interferon-gamma and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells.
    Wedgwood JF; Hatam L; Bonagura VR
    Cell Immunol; 1988 Jan; 111(1):1-9. PubMed ID: 3123068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-dependent cell-mediated cytotoxicity against HLA-A, HLA-B and HLA-DR specificities.
    Akiyama N; Ohsawa N; Kano K
    Int Arch Allergy Appl Immunol; 1984; 74(3):286-8. PubMed ID: 6327536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
    van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
    J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
    Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
    Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human class II antigens. Implication of carbohydrate in the determinants recognized by several antihuman class II monoclonal antibodies.
    Sparrow RL; Vaughan HA; McKenzie IF
    Transplantation; 1986 Dec; 42(6):647-52. PubMed ID: 2431525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody OKT3-induced T cell proliferation: differential role of HLA class II determinants expressed by T cells and monocytes.
    Manzo C; Ruggiero G; del Vecchio L; Racioppi L; Pirozzi G; Temponi M; Ferrone S; Fontana S; Zappacosta S
    Cell Immunol; 1990 Jan; 125(1):79-91. PubMed ID: 1688405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assignment of determinants recognized by human alloantisera to HLA-D-subregion molecules by a lysostrip technique.
    Nuñez G; Stastny P
    Tissue Antigens; 1986 Apr; 27(4):185-95. PubMed ID: 2425451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
    Komatsu F; Tamiya H
    Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human myelin basic protein-specific cytolytic T lymphocyte clones are functionally restricted by HLA class II gene products.
    Weber WE; Vandermeeren MM; Raus JC; Buurman WA
    Cell Immunol; 1989 Apr; 120(1):145-53. PubMed ID: 2467752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms by which HLA-class II molecules protect human B lymphoid tumour cells against NK- and LAK-mediated cytolysis.
    Lobo PI; Chang MY; Mellins E
    Immunology; 1996 Aug; 88(4):625-9. PubMed ID: 8881767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.